Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data
Autoren
Agostini H, Mulyukov Z, Tsilimbaris M, Calvo P, Bucher F, Gaucher D, Pigeolet E, Colafrancesco V, Clemens A
Journal
Curr Eye Res
Veröffentlichungsdatum
2020
Impact Factor
1.640
Abstract
Weitere IDs
Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens